Vagus Nerve Stimulator and Transvenous Pacemaker Interactions

Patient Selection and Device Placement

In non-pacemaker-dependent patients, the risk of interference from a vagus nerve stimulator is lower but still requires careful evaluation, according to the European Heart Journal 1
The American Heart Association, as reported in Circulation, notes that temporary transvenous pacing wires are particularly vulnerable to electromagnetic interference due to lack of fixation mechanisms and increased susceptibility to external electrical potentials 2

The American College of Cardiology recommends that if VNS therapy is essential in a patient with temporary transvenous pacing, consideration should be given to delaying VNS activation until permanent pacing is established 3
The European Society of Cardiology, as noted in a study published in a journal similar to the European Heart Journal, suggests that testing must occur at maximum VNS output settings and highest ICD/pacemaker sensitivity settings to identify potential interactions, although the exact journal was not specified 1

The American Heart Association, as reported in Circulation, states that dislodgement rates reach 16% with temporary wires, with 50% occurring within the first 24 hours, highlighting the need for careful management 2
The Heart Rhythm Society, in a guideline similar to those published in the Journal of the American College of Cardiology, advises that continuous arrhythmia monitoring is mandatory for all patients with temporary transvenous pacing until the device is removed or replaced with a permanent system 2

Pacemaker dependency is a critical factor in patients with a vagus nerve stimulator, as any sensing abnormality could have immediate hemodynamic consequences, particularly in pacemaker-dependent patients, according to the American College of Cardiology 4

The American College of Cardiology recommends that each device combination should undergo individualized testing, as electromagnetic characteristics vary by manufacturer and model, to ensure safe coexistence of a vagus nerve stimulator and a transvenous pacemaker 4